A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 2, 2006, Pages 455-460

  Blackstock, A William ^a   Farmer, Michael R ^a   Lovato, James ^a   Mishra, Girish ^a   Melin, Susan A ^a   Oaks, Timothy ^a   Aklilu, Mabea ^a   Clark, Paige B ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

18 F fluoro deoxy D glucose; Chemoradiation; Esophageal cancer; Positron emission tomography

Indexed keywords

CHEMOTHERAPY; COMPUTER SYSTEMS; ENDOSCOPY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; ULTRASONICS;

18-F-FLUORO-DEOXY-D-GLUCOSE; CHEMORADIATION; ESOPHAGEAL CANCER;

ONCOLOGY;

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 30544452120     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.07.959     Document Type: Article

References (22)

1. A. Jemal, T. Murray, E. Ward Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. A. Herskovic, K. Martz, M. al-Sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
3. M. al-Sarraf, K. Martz, A. Herskovic Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer An intergroup study J Clin Oncol 15 1997 277 284
4. B.D. Minsky, T.F. Pajak, R.J. Ginsberg INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
5. M. Stahl, M. Stuschke, N. Lehmann Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310 2317
6. M. Hiele, P. De Leyn, P. Schurmans Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction Gastrointest Endosc 45 1997 381 386
7. S. Natsugoe, H. Yoshinaka, T. Morinaga Ultrasonographic detection of lymph-node metastasis in superficial carcinoma of the esophagus Endoscopy 28 1996 674 679
8. M.J. Krasna, C.E. Reed, D. Nedzwiecki CALGB 9380 A prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer Ann Thorac Surg 71 2001 1073 1079
9. R. Bar-Shalom, A.Y. Valdivia, M.D. Blaufox PET imaging in oncology Semin Nucl Med 30 2000 150 185
10. P. Flamen Positron emission tomography in gastric and esophageal cancer Curr Opin Oncol 16 2004 359 363
11. H. Kato, H. Kuwano, M. Nakajima Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 2002 921 928
12. W. Kneist, M. Schreckenberger, P. Bartenstein Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma Arch Surg 139 2004 1043 1049
13. M.I. Block, G.A. Patterson, R.S. Sundaresan Improvement in staging of esophageal cancer with the addition of positron emission tomography Ann Thorac Surg 64 1997 770 776 discussion 776-777
14. T. Lerut, P. Flamen, N. Ectors Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction A prospective study based on primary surgery with extensive lymphadenopathy Ann Surg 232 2000 743 752
15. J.D. Luketich, P.R. Schauer, C.C. Meltzer Role of positron emission tomography in staging esophageal cancer Ann Thorac Surg 64 1997 765 769
16. J.D. Luketich, D.M. Friedman, T.L. Weigel Evaluation of distant metastases in esophageal cancer 100 consecutive positron emission tomography scans Ann Thorac Surg 68 1999 1133 1136 discussion 1136-1137
17. J.Y. Choi, H.-J. Jang, Y.M. Shim 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery Prognostic implications J Nucl Med 45 2004 1843 1850
18. L. Coia, E. Soffen, T. Schultheiss Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy Cancer 71 1993 281 286
19. N. Choi, S.D. Park, T. Lynch Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles of adjuvant chemoradiotherapy for resectable esophageal carcinoma Mature results of a Phase II study Int J Radiat Oncol Biol Phys 60 2004 111 122
20. J.-L. Lee, S.I. Park, S.-B. Kim A single institutional phase III trial of preoperative chemotherapy and hyperfractionated radiotherapy plus surgery versus surgery alone for resectable esophageal squamous carcinoma Ann Oncol 15 2004 947 954
21. S.G. Urba, M.B. Orringer, M. Iannettoni Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma Cancer 98 2003 2177 2183
22. B. Jeremic, Y. Shibamoto, L. Acimovic Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus A Phase II study Int J Radiat Oncol Biol Phys 40 1998 1061 1066